9/16/11 Contest Update
We’re all “rogue traders” now! No doubt that’s what they’ll be calling investors after the next stock market crash.
Here’s Matt Taibbi’s take on the latest “rogue trader” scandal:
rollingstone.com
No crash this week, however, as hopeful investors did more buying than selling. At Friday’s close, the NBI was up 4.80% YTD (vs. up .59% YTD a week ago) and the Contest median was down -1.66% YTD (vs. down -5.54% YTD a week ago). The Nasdaq Composite Index was down -1.15% YTD (vs. down -6.97% YTD a week ago).
GENE’s portfolio (up 52.29 % YTD) remained our leader, while JIBAC’s portfolio (up 42.88%YTD) held on to second place and ROCKY’s portfolio (up 39.27% YTD) regained third place.
At Friday's close, 18 of the 38 Contest portfolios were in the black, while 13 of the 38 were beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: The ICGN cash from Pfizer’s $6 tender appeared in in my real-life account on Wednesday, 9/14. So, as indicated in last week’s update, I used 9/14 closing prices to reallocate the Pfizer proceeds for those Contest portfolios holding ICGN (BIOFISH, GENE, JIBAC, RKRW).
Be kind to yourself this weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
9/16/11
Rank Name Profit/Loss
1 GENE 52,294
2 JIBAC 42,882
3 ROCKY 39,269
4 MCBIO 38,134
5 FIB 27,787
6 GHMM 20,390
7 RRGE 18,186
8 IJF 14,602
9 JULIUS 13,274
10 RKRW 10,281
Week's Top 5 Gainers
Symbol 9/9 9/16 % change
DRRX 1.43 1.87 30.77%
ARNA 1.25 1.56 24.80%
BMTI 3.30 4.04 22.42%
OREX 1.28 1.55 21.09%
TLON.OB 0.91 1.09 19.78%
Week's Top 5 Losers
Symbol 9/9 9/16 % change
CBPO 8.50 7.42 -12.71%
MSHL 1.51 1.33 -11.92%
ROSG 1.28 1.14 -10.94%
KOOL 1.63 1.48 -9.20%
NRGX.OB 0.55 0.50 -9.09% |
